Program (Tentative)

09:00~09:15

General Meeting

09:15~09:25

Opening Remarks

09:25~10:15

Presidential Lecture

New strategy to induce tolerance for organ transplantation

Chairman: Miyuki Azuma (Department of Molecular Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University)
Speaker: Ko Okumura (Department of Immunology/Atopy Research Center, Juntendo University School of Medicine)

10:15~11:05

Educational Lecture 1

Future perspective of precision medicine in connective tissue disease

Chairman: Hisanori Umehara (Department of Rheumatology, Nagahama City Hospital)
Speaker: Masataka Kuwana (Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine)

11:05~11:55

Educational Lecture 2

Precision Medicine for prophylaxis and treatment of allergic diseases

Chairman: Jiro Kitaura (Atopy Research Center, Juntendo University Graduate School of Medicine)
Speaker: Masami Narita (Division of Allergy, National Center for Child Health and Development)

12:00~13:00

Luncheon Seminar

Cosponsored by Mitsubishi Tanabe Pharma Corporation

Chairman: Ko Okumura (Department of Immunology/Atopy Research Center, Juntendo University School of Medicine)

Novel Bio Products and Post Bio Strategy against Rheumatic Disease

Speaker: Kusuki Nishioka (National Graduate Institute for Policy Studies)

Status and issues of the cell therapies in the act on the safety of regenerative medicine

Speaker: Morikuni Tobita (Medical Technology Innovation Center, Juntendo university)

13:00~13:30

Company Presentation

13:30~14:00

Coffee Break (Poster Session・Exhibition Booth)

14:00~14:50

Educational Lecture 3

Chimeric antigen receptor T-cell therapy

Chairman: Kazuyoshi Takeda (Division of Cell Biology, Research Support Center, Juntendo University Graduate School of Medicine)
Speaker: Yozo Nakazawa (Department of Pediatrics, Shinshu University School of Medicine)

14:50~15:40

Thomas Jefferson Memorial Lecture

Cosponsored by US Noguchi Medical Research Institute

Recent Progress in Cancer Immunotherapy in the United States

Chairman: Kenichiro Hasumi (Thomas Jefferson University)
Speaker: Takami Sato (Department of Medical Oncology, Thomas Jefferson University)

15:40~16:00

Coffee Break (Poster Session・Exhibition Booth)

16:00~17:50

Clinical Practical Session

Speakers: Chairman: Hirokazu Matsushita(Department of Immunotherapeutics, The University of Tokyo Hospital)
16:00-16:30  1. The current clinical development of and future challenges in utilizing immune checkpoint inhibitors
Shigehisa Kitano (Department of Experimental Therapeutics, National Cancer Center Hospital)
16:30-17:00  2. Regeneration of tumor antigen-specific T cells using the iPSC technology
-application of the method to the personalized medicine by targeting neoantigen -

Hiroshi Kawamoto (Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University)
17:00-17:30  3. Personalized cancer immunotherapy based on NGS data
Takahiro Karasaki (Department of Thoracic Surgery, The University of Tokyo Hospital)

17:50~18:00

Closing Remarks

8:00~19:30

Closing Reception

Page Top
Copyright © 2017 The 23rd International Congress of Personalized Medicine All Rights Reserved.